Author:
Kress Hans G.,Von der Laage Dorothea,Hoerauf Klaus H.,Nolte Thomas,Heiskanen Tarja,Petersen Rasmus,Lundorff Lena,Sabatowski Rainer,Krenn Herbert,Rosland Jan H.,Saedder Eva A.,Jensen Niels-Henrik
Subject
Anesthesiology and Pain Medicine,Clinical Neurology,General Nursing
Reference45 articles.
1. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control;Jeal;Drugs,1997
2. System functionality and physicochemical model of fentanyl transdermal system;Gupta;J Pain Symptom Manage,1992
3. Pharmacokinetic characterisation of transdermal delivery systems;Berner;Clin Pharmacokinet,1994
4. Drug delivery systems. 6. Transdermal drug delivery;Ranade;J Clin Pharmacol,1991
5. U.S. and Drug Administration. Center for Drug Evaluation and Research. Alert for Healthcare professionals: fentanyl transdermal system (marketed as Duragesic). Available at http://www.fda.gov/cder/drug/InfoSheets/HCP/fentanylHCP.htm. Accessed May 28, 2008.
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献